ANDREW MERRICK: Open Payments
NPI 1629551221 · WASILLA, AK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$473 in 17 payments from 7 companies in 2025. Trend: 2023 $156 · 2024 $200 · 2025 $473
Food & beverage: $389Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $208 |
| Janssen Biotech, Inc. | 1 | $84 |
| Medtronic, Inc. | 2 | $47 |
| Boston Scientific Corporation | 2 | $46 |
| Collegium Pharmaceutical, Inc. | 2 | $37 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $30 |
| Aimmune Therapeutics, Inc. | 1 | $20 |
Products named: QULIPTA, TREMFYA, UBRELVY, Belbuca, RELISTOR, SYNCHROMEDII, General - Pain Management, WaveWriter Alpha Prime 16.
Industry payments across AK — which companies pay providers there.
